Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical tranexamic acid for macroscopic haematuria requiring continuous bladder irrigation
ACTRN12626000559314Phase 2Not yet recruiting
- Sponsor
- Illawarra Shoalhaven Local Health District
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in hematuria comparing Intravesical tranexamic acid with Intravesical saline placebo (2 arms). Primary endpoint: Duration of continuous bladder irrigation. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
hematuria
Beyond the preview
Go deeper on ACTRN12626000559314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000559314.